THYROCARE / NSE / Healthcare Facilities
Thyrocare Technologies
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High537.97
Target Low292.42
Target Mean1.5
Target Median62.5
Risk Metrics
Overall RiskBalanced risk
Board Risk37.9
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Stocks to buy for the short term: Market analysts recommend five promising stocks for the next 1-2 weeks, highlighting bullish trends and strong support zones. Stocks like Bank of India and Thyrocare Technologies show potential for growth, backed by robust technical indicators.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Bank of India, Thyrocare Technologies, Can Fin Home, Ashok Leyland, and CEAT
Dividend stocks attract investors for income and stability. Key metrics include dividend yield, calculated as annual dividends divided by market price. Small-cap stocks like MSTC and PTC India show strong yields over 5%, highlighting their profitability and consistent payout records.
Stocks to buy for short term: Axis Securities has recommended Welspun Living, Samvardhana Motherson International and Cummins India shares, while Asit C. Mehta Investment Intermediates has recommended Thyrocare Technologies and Sumitomo Chemical India shares to buy for short-term.
Thyrocare Technologies' shares dropped over 67% on November 28 due to a 2:1 bonus issue, tripling share count while adjusting the price. The stock opened at ₹ 501, reflecting the adjustment, and traded slightly lower at ₹ 489 afterward.
MarketSmith India reveals its top stock recommendations for today, 14 November. Get expert insights into the best-performing stocks to guide your investment decisions.
Thyrocare Technologies experienced a 16% stock surge to ₹ 1,474 following positive Q2 results and a bonus issue announcement. The company reported 22% revenue growth and an 82% increase in PAT, while expanding its lab presence.
Thyrocare Technologies announced a 2:1 bonus share issue and an interim dividend of ₹ 07. The bonus aims to enhance liquidity and broaden the shareholder base. The company reported a 22% revenue growth, with PAT surging 82% YoY to ₹ 47.90 crore.
© SharekeyX | Rusaka Technologies 2024-2026

